InvestorsHub Logo
Followers 0
Posts 330
Boards Moderated 1
Alias Born 07/28/2023

Re: None

Monday, 12/11/2023 12:38:55 PM

Monday, December 11, 2023 12:38:55 PM

Post# of 64560
There are thousands of stem cell-related clinical trials currently progressing (TSOI does not have a single one). There are also scores of companies that, unlike TSOI, have actually established themselves in the space (you know companies like AstraZeneca, Amgen, Sanofi, Gilead, Vertex and many others whose main “products” aren’t blueberry and broccoli supplements).

Advances in stem cell research and application will likely not benefit TSOI in the least. TSOI has been around for more than 15 years and does not have a single current clinical trial registered. They have made some supplements, hand creams and hats but the thing that they are far and away best at creating is BILLIONS of dilutive shares. Coming out from under historical low pps and this mountain of additional shares will require far more than Dixon has ever proved capable of providing. So long as he can keep financing that Idaho lifestyle I doubt he cares much.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent TSOI News